Explore › Condition › Gestational Diabetes
Condition

Gestational Diabetes

Also known as: DIABETES PREGN IND Diabetes Mellitus, Gestational Diabetes mellitus arising in pregnancy Diabetes, Gestational Diabetes, Pregnancy Induced Diabetes, Pregnancy-Induced GDM GDM - Gestational diabetes mellitus GDM - gestational diabetes mellitus Gestational Diabetes Gestational Diabetes Mellitus Gestational diabetes +8 more
6 findings 1 paper 4 related entities View in graph →

Related entities

interventions
dolutegravir-based antiretroviral therapy1
outcomes
Gestational diabetes mellitus2
populations
Pregnant Women2
studys
PMC83737292

Findings (50)

None
null

Pregnant women living with HIV on ART in Botswana were not at increased risk for gestational diabetes compared to pregnant women without HIV, after adjusting for age, education, BMI, and gravidity.

Effect: null; aOR=0.83; CI: 95% CI=0.37, 1.85

Size: aOR=0.83 CI: 95% CI=0.37, 1.85
PMC8373729
Finding details → · Paper → · Graph →
None
null

Pregnant women living with HIV on ART in Botswana were not at increased risk for gestational diabetes compared to pregnant women without HIV, after adjusting for age, education, BMI, and gravidity.

Effect: null; aOR=0.83; CI: 95% CI=0.37, 1.85

Size: aOR=0.83 CI: 95% CI=0.37, 1.85
PMC8373729
Finding details → · Paper → · Graph →
None
null

Pregnant women living with HIV on ART in Botswana were not at increased risk for gestational diabetes compared to pregnant women without HIV, after adjusting for age, education, BMI, and gravidity.

Effect: null; aOR=0.83; CI: 95% CI=0.37, 1.85

Size: aOR=0.83 CI: 95% CI=0.37, 1.85
PMC8373729
Finding details → · Paper → · Graph →
None
null

Pregnant women living with HIV on ART in Botswana were not at increased risk for gestational diabetes compared to pregnant women without HIV, after adjusting for age, education, BMI, and gravidity.

Effect: null; aOR=0.83; CI: 95% CI=0.37, 1.85

Size: aOR=0.83 CI: 95% CI=0.37, 1.85
PMC8373729
Finding details → · Paper → · Graph →
None
null

Pregnant women living with HIV on ART in Botswana were not at increased risk for gestational diabetes compared to pregnant women without HIV, after adjusting for age, education, BMI, and gravidity.

Effect: null; aOR=0.83; CI: 95% CI=0.37, 1.85

Size: aOR=0.83 CI: 95% CI=0.37, 1.85
PMC8373729
Finding details → · Paper → · Graph →
None
null

Pregnant women living with HIV on ART in Botswana were not at increased risk for gestational diabetes compared to pregnant women without HIV, after adjusting for age, education, BMI, and gravidity.

Effect: null; aOR=0.83; CI: 95% CI=0.37, 1.85

Size: aOR=0.83 CI: 95% CI=0.37, 1.85
PMC8373729
Finding details → · Paper → · Graph →
None
null

Pregnant women living with HIV on ART in Botswana were not at increased risk for gestational diabetes compared to pregnant women without HIV, after adjusting for age, education, BMI, and gravidity.

Effect: null; aOR=0.83; CI: 95% CI=0.37, 1.85

Size: aOR=0.83 CI: 95% CI=0.37, 1.85
PMC8373729
Finding details → · Paper → · Graph →
None
null

Pregnant women living with HIV on ART in Botswana were not at increased risk for gestational diabetes compared to pregnant women without HIV, after adjusting for age, education, BMI, and gravidity.

Effect: null; aOR=0.83; CI: 95% CI=0.37, 1.85

Size: aOR=0.83 CI: 95% CI=0.37, 1.85
PMC8373729
Finding details → · Paper → · Graph →
None
null

Pregnant women living with HIV on ART in Botswana were not at increased risk for gestational diabetes compared to pregnant women without HIV, after adjusting for age, education, BMI, and gravidity.

Effect: null; aOR=0.83; CI: 95% CI=0.37, 1.85

Size: aOR=0.83 CI: 95% CI=0.37, 1.85
PMC8373729
Finding details → · Paper → · Graph →
None
null

Pregnant women living with HIV on ART in Botswana were not at increased risk for gestational diabetes compared to pregnant women without HIV, after adjusting for age, education, BMI, and gravidity.

Effect: null; aOR=0.83; CI: 95% CI=0.37, 1.85

Size: aOR=0.83 CI: 95% CI=0.37, 1.85
PMC8373729
Finding details → · Paper → · Graph →
None
null

Pregnant women living with HIV on ART in Botswana were not at increased risk for gestational diabetes compared to pregnant women without HIV, after adjusting for age, education, BMI, and gravidity.

Effect: null; aOR=0.83; CI: 95% CI=0.37, 1.85

Size: aOR=0.83 CI: 95% CI=0.37, 1.85
PMC8373729
Finding details → · Paper → · Graph →
None
null

Pregnant women living with HIV on ART in Botswana were not at increased risk for gestational diabetes compared to pregnant women without HIV, after adjusting for age, education, BMI, and gravidity.

Effect: null; aOR=0.83; CI: 95% CI=0.37, 1.85

Size: aOR=0.83 CI: 95% CI=0.37, 1.85
PMC8373729
Finding details → · Paper → · Graph →
None
null

Pregnant women living with HIV on ART in Botswana were not at increased risk for gestational diabetes compared to pregnant women without HIV, after adjusting for age, education, BMI, and gravidity.

Effect: null; aOR=0.83; CI: 95% CI=0.37, 1.85

Size: aOR=0.83 CI: 95% CI=0.37, 1.85
PMC8373729
Finding details → · Paper → · Graph →
None
null

Pregnant women living with HIV on ART in Botswana were not at increased risk for gestational diabetes compared to pregnant women without HIV, after adjusting for age, education, BMI, and gravidity.

Effect: null; aOR=0.83; CI: 95% CI=0.37, 1.85

Size: aOR=0.83 CI: 95% CI=0.37, 1.85
PMC8373729
Finding details → · Paper → · Graph →
None
null

Pregnant women living with HIV on ART in Botswana were not at increased risk for gestational diabetes compared to pregnant women without HIV, after adjusting for age, education, BMI, and gravidity.

Effect: null; aOR=0.83; CI: 95% CI=0.37, 1.85

Size: aOR=0.83 CI: 95% CI=0.37, 1.85
PMC8373729
Finding details → · Paper → · Graph →
None
null

Pregnant women living with HIV on ART in Botswana were not at increased risk for gestational diabetes compared to pregnant women without HIV, after adjusting for age, education, BMI, and gravidity.

Effect: null; aOR=0.83; CI: 95% CI=0.37, 1.85

Size: aOR=0.83 CI: 95% CI=0.37, 1.85
PMC8373729
Finding details → · Paper → · Graph →
None
null

Pregnant women living with HIV on ART in Botswana were not at increased risk for gestational diabetes compared to pregnant women without HIV, after adjusting for age, education, BMI, and gravidity.

Effect: null; aOR=0.83; CI: 95% CI=0.37, 1.85

Size: aOR=0.83 CI: 95% CI=0.37, 1.85
PMC8373729
Finding details → · Paper → · Graph →
None
null

Pregnant women living with HIV on ART in Botswana were not at increased risk for gestational diabetes compared to pregnant women without HIV, after adjusting for age, education, BMI, and gravidity.

Effect: null; aOR=0.83; CI: 95% CI=0.37, 1.85

Size: aOR=0.83 CI: 95% CI=0.37, 1.85
PMC8373729
Finding details → · Paper → · Graph →
None
null

Pregnant women living with HIV on ART in Botswana were not at increased risk for gestational diabetes compared to pregnant women without HIV, after adjusting for age, education, BMI, and gravidity.

Effect: null; aOR=0.83; CI: 95% CI=0.37, 1.85

Size: aOR=0.83 CI: 95% CI=0.37, 1.85
PMC8373729
Finding details → · Paper → · Graph →
None
null

Pregnant women living with HIV on ART in Botswana were not at increased risk for gestational diabetes compared to pregnant women without HIV, after adjusting for age, education, BMI, and gravidity.

Effect: null; aOR=0.83; CI: 95% CI=0.37, 1.85

Size: aOR=0.83 CI: 95% CI=0.37, 1.85
PMC8373729
Finding details → · Paper → · Graph →
None
null

Pregnant women living with HIV on ART in Botswana were not at increased risk for gestational diabetes compared to pregnant women without HIV, after adjusting for age, education, BMI, and gravidity.

Effect: null; aOR=0.83; CI: 95% CI=0.37, 1.85

Size: aOR=0.83 CI: 95% CI=0.37, 1.85
PMC8373729
Finding details → · Paper → · Graph →
None
null

Pregnant women living with HIV on ART in Botswana were not at increased risk for gestational diabetes compared to pregnant women without HIV, after adjusting for age, education, BMI, and gravidity.

Effect: null; aOR=0.83; CI: 95% CI=0.37, 1.85

Size: aOR=0.83 CI: 95% CI=0.37, 1.85
PMC8373729
Finding details → · Paper → · Graph →
None
null

Pregnant women living with HIV on ART in Botswana were not at increased risk for gestational diabetes compared to pregnant women without HIV, after adjusting for age, education, BMI, and gravidity.

Effect: null; aOR=0.83; CI: 95% CI=0.37, 1.85

Size: aOR=0.83 CI: 95% CI=0.37, 1.85
PMC8373729
Finding details → · Paper → · Graph →
None
null

Pregnant women living with HIV on ART in Botswana were not at increased risk for gestational diabetes compared to pregnant women without HIV, after adjusting for age, education, BMI, and gravidity.

Effect: null; aOR=0.83; CI: 95% CI=0.37, 1.85

Size: aOR=0.83 CI: 95% CI=0.37, 1.85
PMC8373729
Finding details → · Paper → · Graph →
None
null

Pregnant women living with HIV on ART in Botswana were not at increased risk for gestational diabetes compared to pregnant women without HIV, after adjusting for age, education, BMI, and gravidity.

Effect: null; aOR=0.83; CI: 95% CI=0.37, 1.85

Size: aOR=0.83 CI: 95% CI=0.37, 1.85
PMC8373729
Finding details → · Paper → · Graph →
None
null

Pregnant women living with HIV on ART in Botswana were not at increased risk for gestational diabetes compared to pregnant women without HIV, after adjusting for age, education, BMI, and gravidity.

Effect: null; aOR=0.83; CI: 95% CI=0.37, 1.85

Size: aOR=0.83 CI: 95% CI=0.37, 1.85
PMC8373729
Finding details → · Paper → · Graph →
None
null

Pregnant women living with HIV on ART in Botswana were not at increased risk for gestational diabetes compared to pregnant women without HIV, after adjusting for age, education, BMI, and gravidity.

Effect: null; aOR=0.83; CI: 95% CI=0.37, 1.85

Size: aOR=0.83 CI: 95% CI=0.37, 1.85
PMC8373729
Finding details → · Paper → · Graph →
None
improvement

Pregnant women living with HIV receiving dolutegravir-based ART had a 66% lower risk for gestational diabetes compared to those on efavirenz-based ART after adjusting for age, BMI, gravidity, CD4, and

Effect: improvement; aOR=0.34; CI: 95% CI=0.12, 0.97

Size: aOR=0.34 CI: 95% CI=0.12, 0.97
PMC8373729
Finding details → · Paper → · Graph →
None
improvement

Pregnant women living with HIV receiving dolutegravir-based ART had a 66% lower risk for gestational diabetes compared to those on efavirenz-based ART after adjusting for age, BMI, gravidity, CD4, and

Effect: improvement; aOR=0.34; CI: 95% CI=0.12, 0.97

Size: aOR=0.34 CI: 95% CI=0.12, 0.97
PMC8373729
Finding details → · Paper → · Graph →
None
improvement

Pregnant women living with HIV receiving dolutegravir-based ART had a 66% lower risk for gestational diabetes compared to those on efavirenz-based ART after adjusting for age, BMI, gravidity, CD4, and

Effect: improvement; aOR=0.34; CI: 95% CI=0.12, 0.97

Size: aOR=0.34 CI: 95% CI=0.12, 0.97
PMC8373729
Finding details → · Paper → · Graph →
None
improvement

Pregnant women living with HIV receiving dolutegravir-based ART had a 66% lower risk for gestational diabetes compared to those on efavirenz-based ART after adjusting for age, BMI, gravidity, CD4, and

Effect: improvement; aOR=0.34; CI: 95% CI=0.12, 0.97

Size: aOR=0.34 CI: 95% CI=0.12, 0.97
PMC8373729
Finding details → · Paper → · Graph →
None
improvement

Pregnant women living with HIV receiving dolutegravir-based ART had a 66% lower risk for gestational diabetes compared to those on efavirenz-based ART after adjusting for age, BMI, gravidity, CD4, and

Effect: improvement; aOR=0.34; CI: 95% CI=0.12, 0.97

Size: aOR=0.34 CI: 95% CI=0.12, 0.97
PMC8373729
Finding details → · Paper → · Graph →
None
improvement

Pregnant women living with HIV receiving dolutegravir-based ART had a 66% lower risk for gestational diabetes compared to those on efavirenz-based ART after adjusting for age, BMI, gravidity, CD4, and

Effect: improvement; aOR=0.34; CI: 95% CI=0.12, 0.97

Size: aOR=0.34 CI: 95% CI=0.12, 0.97
PMC8373729
Finding details → · Paper → · Graph →
None
improvement

Pregnant women living with HIV receiving dolutegravir-based ART had a 66% lower risk for gestational diabetes compared to those on efavirenz-based ART after adjusting for age, BMI, gravidity, CD4, and

Effect: improvement; aOR=0.34; CI: 95% CI=0.12, 0.97

Size: aOR=0.34 CI: 95% CI=0.12, 0.97
PMC8373729
Finding details → · Paper → · Graph →
None
improvement

Pregnant women living with HIV receiving dolutegravir-based ART had a 66% lower risk for gestational diabetes compared to those on efavirenz-based ART after adjusting for age, BMI, gravidity, CD4, and

Effect: improvement; aOR=0.34; CI: 95% CI=0.12, 0.97

Size: aOR=0.34 CI: 95% CI=0.12, 0.97
PMC8373729
Finding details → · Paper → · Graph →
None
improvement

Pregnant women living with HIV receiving dolutegravir-based ART had a 66% lower risk for gestational diabetes compared to those on efavirenz-based ART after adjusting for age, BMI, gravidity, CD4, and

Effect: improvement; aOR=0.34; CI: 95% CI=0.12, 0.97

Size: aOR=0.34 CI: 95% CI=0.12, 0.97
PMC8373729
Finding details → · Paper → · Graph →
None
improvement

Pregnant women living with HIV receiving dolutegravir-based ART had a 66% lower risk for gestational diabetes compared to those on efavirenz-based ART after adjusting for age, BMI, gravidity, CD4, and

Effect: improvement; aOR=0.34; CI: 95% CI=0.12, 0.97

Size: aOR=0.34 CI: 95% CI=0.12, 0.97
PMC8373729
Finding details → · Paper → · Graph →
None
improvement

Pregnant women living with HIV receiving dolutegravir-based ART had a 66% lower risk for gestational diabetes compared to those on efavirenz-based ART after adjusting for age, BMI, gravidity, CD4, and

Effect: improvement; aOR=0.34; CI: 95% CI=0.12, 0.97

Size: aOR=0.34 CI: 95% CI=0.12, 0.97
PMC8373729
Finding details → · Paper → · Graph →
None
improvement

Pregnant women living with HIV receiving dolutegravir-based ART had a 66% lower risk for gestational diabetes compared to those on efavirenz-based ART after adjusting for age, BMI, gravidity, CD4, and

Effect: improvement; aOR=0.34; CI: 95% CI=0.12, 0.97

Size: aOR=0.34 CI: 95% CI=0.12, 0.97
PMC8373729
Finding details → · Paper → · Graph →
None
improvement

Pregnant women living with HIV receiving dolutegravir-based ART had a 66% lower risk for gestational diabetes compared to those on efavirenz-based ART after adjusting for age, BMI, gravidity, CD4, and

Effect: improvement; aOR=0.34; CI: 95% CI=0.12, 0.97

Size: aOR=0.34 CI: 95% CI=0.12, 0.97
PMC8373729
Finding details → · Paper → · Graph →
None
improvement

Pregnant women living with HIV receiving dolutegravir-based ART had a 66% lower risk for gestational diabetes compared to those on efavirenz-based ART after adjusting for age, BMI, gravidity, CD4, and

Effect: improvement; aOR=0.34; CI: 95% CI=0.12, 0.97

Size: aOR=0.34 CI: 95% CI=0.12, 0.97
PMC8373729
Finding details → · Paper → · Graph →
None
improvement

Pregnant women living with HIV receiving dolutegravir-based ART had a 66% lower risk for gestational diabetes compared to those on efavirenz-based ART after adjusting for age, BMI, gravidity, CD4, and

Effect: improvement; aOR=0.34; CI: 95% CI=0.12, 0.97

Size: aOR=0.34 CI: 95% CI=0.12, 0.97
PMC8373729
Finding details → · Paper → · Graph →
None
improvement

Pregnant women living with HIV receiving dolutegravir-based ART had a 66% lower risk for gestational diabetes compared to those on efavirenz-based ART after adjusting for age, BMI, gravidity, CD4, and

Effect: improvement; aOR=0.34; CI: 95% CI=0.12, 0.97

Size: aOR=0.34 CI: 95% CI=0.12, 0.97
PMC8373729
Finding details → · Paper → · Graph →
None
improvement

Pregnant women living with HIV receiving dolutegravir-based ART had a 66% lower risk for gestational diabetes compared to those on efavirenz-based ART after adjusting for age, BMI, gravidity, CD4, and

Effect: improvement; aOR=0.34; CI: 95% CI=0.12, 0.97

Size: aOR=0.34 CI: 95% CI=0.12, 0.97
PMC8373729
Finding details → · Paper → · Graph →
None
improvement

Pregnant women living with HIV receiving dolutegravir-based ART had a 66% lower risk for gestational diabetes compared to those on efavirenz-based ART after adjusting for age, BMI, gravidity, CD4, and

Effect: improvement; aOR=0.34; CI: 95% CI=0.12, 0.97

Size: aOR=0.34 CI: 95% CI=0.12, 0.97
PMC8373729
Finding details → · Paper → · Graph →
None
improvement

Pregnant women living with HIV receiving dolutegravir-based ART had a 66% lower risk for gestational diabetes compared to those on efavirenz-based ART after adjusting for age, BMI, gravidity, CD4, and

Effect: improvement; aOR=0.34; CI: 95% CI=0.12, 0.97

Size: aOR=0.34 CI: 95% CI=0.12, 0.97
PMC8373729
Finding details → · Paper → · Graph →
None
improvement

Pregnant women living with HIV receiving dolutegravir-based ART had a 66% lower risk for gestational diabetes compared to those on efavirenz-based ART after adjusting for age, BMI, gravidity, CD4, and

Effect: improvement; aOR=0.34; CI: 95% CI=0.12, 0.97

Size: aOR=0.34 CI: 95% CI=0.12, 0.97
PMC8373729
Finding details → · Paper → · Graph →
None
improvement

Pregnant women living with HIV receiving dolutegravir-based ART had a 66% lower risk for gestational diabetes compared to those on efavirenz-based ART after adjusting for age, BMI, gravidity, CD4, and

Effect: improvement; aOR=0.34; CI: 95% CI=0.12, 0.97

Size: aOR=0.34 CI: 95% CI=0.12, 0.97
PMC8373729
Finding details → · Paper → · Graph →
None
improvement

Pregnant women living with HIV receiving dolutegravir-based ART had a 66% lower risk for gestational diabetes compared to those on efavirenz-based ART after adjusting for age, BMI, gravidity, CD4, and

Effect: improvement; aOR=0.34; CI: 95% CI=0.12, 0.97

Size: aOR=0.34 CI: 95% CI=0.12, 0.97
PMC8373729
Finding details → · Paper → · Graph →
None
improvement

Pregnant women living with HIV receiving dolutegravir-based ART had a 66% lower risk for gestational diabetes compared to those on efavirenz-based ART after adjusting for age, BMI, gravidity, CD4, and

Effect: improvement; aOR=0.34; CI: 95% CI=0.12, 0.97

Size: aOR=0.34 CI: 95% CI=0.12, 0.97
PMC8373729
Finding details → · Paper → · Graph →

Papers (1)